Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Revenue (2017 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Revenue data on record, last reported at -$7.9 million in Q4 2012.

  • For Q4 2012, Revenue fell 383.05% year-over-year to -$7.9 million; the TTM value through Mar 2013 reached $680000.0, down 94.66%, while the annual FY2012 figure was $12.7 million, 1273.28% up from the prior year.
  • Revenue reached -$7.9 million in Q4 2012 per SNOA's latest filing, down from $4.8 million in the prior quarter.
  • Across five years, Revenue topped out at $6.3 million in Q1 2012 and bottomed at -$7.9 million in Q4 2012.
  • Average Revenue over 3 years is $1.3 million, with a median of $2.8 million recorded in 2011.
  • The widest YoY moves for Revenue: up 1559.13% in 2012, down 383.05% in 2012.
  • A 3-year view of Revenue shows it stood at $2.3 million in 2010, then rose by 20.62% to $2.8 million in 2011, then crashed by 383.05% to -$7.9 million in 2012.
  • Per Business Quant database, its latest 3 readings for Revenue were -$7.9 million in Q4 2012, $4.8 million in Q3 2012, and $3.8 million in Q2 2012.